The 3 references without contexts in paper V. Yakushev I., M. Pokrovsky V., E. Beskhmelnitsyna A., O. Myasishcheva V., A. Litvinova S., I. Krivoshapova I., S. Demchenko A., В. Якушев И., М. Покровский В., Е. Бесхмельницына А., О. Мясищева В., А. Литвинова С., И. Кривошапова И., С. Демченко А. (2018) “Аргиназа II - новая мишень для создания эндотелиопротекторов // Arginase II - a new target in the development of endothelium protectors” / spz:neicon:vedomostincesmp:y:2015:i:1:p:26-30

17
Hein TW, Zhang C, Wang W. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arterioles: counteracting role of arginase. FASEB J. 2003; (17): 2328–30.
(check this in PDF content)
18
Ignarro LJ, Buga GM, Wei LH. Role of arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation. Proc Natl Acad Sci USA 2001; (98): 4202–08.
(check this in PDF content)
22
Jung AS, Wilson RM, Houser SR, et al. Modulation of contractility by myocytederived arginase in normal and hypertrophied feline myocardium. Am J Physiol Heart Circ Physiol. 2005; (34): 298–305.
(check this in PDF content)